{"count": 3, "results": [{"_id": "23983803", "pmid": 23983803, "pmcid": "PMC3747599", "title": "The Effect of Sodium Tanshinone IIA Sulfate and Simvastatin on Elevated Serum Levels of Inflammatory Markers in Patients with Coronary Heart Disease: A Study Protocol for a Randomized Controlled Trial", "journal": "Evid Based Complement Alternat Med", "authors": ["Shang Q", "Wang H", "Li S", "Xu H"], "date": "2013-01-01T00:00:00Z", "doi": "10.1155/2013/756519", "meta_date_publication": "2013", "meta_volume": "2013", "meta_issue": "", "meta_pages": "756519", "score": 50055.79, "text_hl": "In addition, we also aim to assess the integrative therapy's safety and its efficacy in improving @DISEASE_Angina_Pectoris @DISEASE_MESH:D000787 @@@angina@@@ and @<m>DISEASE_Postthrombotic_Syndrome</m> @DISEASE_MESH:D054070 @@@BSS@@@ symptoms relative to the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ regimen without @GENE_STS @GENE_412 @@@STS@@@. ", "citations": {"NLM": "Shang Q, Wang H, Li S, Xu H. The Effect of Sodium Tanshinone IIA Sulfate and Simvastatin on Elevated Serum Levels of Inflammatory Markers in Patients with Coronary Heart Disease: A Study Protocol for a Randomized Controlled Trial Evid Based Complement Alternat Med. 2013;2013():756519. PMID: 23983803", "BibTeX": "@article{23983803, title={The Effect of Sodium Tanshinone IIA Sulfate and Simvastatin on Elevated Serum Levels of Inflammatory Markers in Patients with Coronary Heart Disease: A Study Protocol for a Randomized Controlled Trial}, author={Shang Q and Wang H and Li S and Xu H}, journal={Evid Based Complement Alternat Med}, volume={2013}, pages={756519}}"}}, {"_id": "31029757", "pmid": 31029757, "title": "UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats.", "journal": "J Ethnopharmacol", "authors": ["Zhao Y", "Nie S", "Yi M", "Wu N", "Wang W", "Zhang Z", "Yao Y", "Wang D"], "date": "2019-09-15T00:00:00Z", "doi": "10.1016/j.jep.2019.111908", "meta_date_publication": "2019 Sep 15", "meta_volume": "241", "meta_issue": "", "meta_pages": "111908", "score": 50051.63, "text_hl": "ETHNOPHARMACOLOGICAL RELEVANCE: @<m>DISEASE_Postthrombotic_Syndrome</m> @DISEASE_MESH:D054070 @@@Blood-stasis syndrome@@@ (@<m>DISEASE_Postthrombotic_Syndrome</m> @DISEASE_MESH:D054070 @@@BSS@@@) is a specific ZHENG type of @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary heart disease@@@ (@DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@CHD@@@) in traditional Chinese medicine (TCM). ", "citations": {"NLM": "Zhao Y, Nie S, Yi M, Wu N, Wang W, Zhang Z, Yao Y, Wang D. UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats. J Ethnopharmacol. 2019 Sep 15;241():111908. PMID: 31029757", "BibTeX": "@article{31029757, title={UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats.}, author={Zhao Y and Nie S and Yi M and Wu N and Wang W and Zhang Z and Yao Y and Wang D}, journal={J Ethnopharmacol}, volume={241}, pages={111908}}"}}, {"_id": "22160946", "pmid": 22160946, "title": "Effect of Chinese drugs for activating blood circulation and detoxifying on indices of thrombosis, inflammatory reaction, and tissue damage in a rabbit model of toxin-heat and blood stasis syndrome.", "journal": "Chin J Integr Med", "authors": ["Xue M", "Yin HJ", "Wu CF", "Ma XJ", "Guo CY", "Huang Y", "Shi DZ", "Chen KJ"], "date": "2013-01-01T00:00:00Z", "doi": "10.1007/s11655-011-0604-7", "meta_date_publication": "2013 Jan", "meta_volume": "19", "meta_issue": "1", "meta_pages": "42-7", "score": 50050.13, "text_hl": "METHODS: Fifty-four @SPECIES_9986 @@@rabbits@@@ were randomized into the normal control group, model group, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ group (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, 0.93 mg/kg per day), ABC group [Xiongshao Capsule, 0.07 g/kg per day], and ABCD group [Xiongshao Capsule, 0.07 g/kg per day, and Huanglian Capsule, 0.14 g/kg per day]. ", "citations": {"NLM": "Xue M, Yin HJ, Wu CF, Ma XJ, Guo CY, Huang Y, Shi DZ, Chen KJ. Effect of Chinese drugs for activating blood circulation and detoxifying on indices of thrombosis, inflammatory reaction, and tissue damage in a rabbit model of toxin-heat and blood stasis syndrome. Chin J Integr Med. 2013 Jan;19(1):42-7. PMID: 22160946", "BibTeX": "@article{22160946, title={Effect of Chinese drugs for activating blood circulation and detoxifying on indices of thrombosis, inflammatory reaction, and tissue damage in a rabbit model of toxin-heat and blood stasis syndrome.}, author={Xue M and Yin HJ and Wu CF and Ma XJ and Guo CY and Huang Y and Shi DZ and Chen KJ}, journal={Chin J Integr Med}, volume={19}, number={1}, pages={42-7}}"}}]}